Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Alabama
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Alabama
| Provider | Medicare | Services |
|---|---|---|
| Graves, Eric MD | $43.58 | 113 |
Alabama Pricing in Context
In Alabama, CPT code 86328 (Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative) carries an average Medicare payment of $43.42 — 2% below the national benchmark of $44.34. 45 providers across the state submitted claims for this procedure in 2023, performing 262 total services. Individual payments in AL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Alabama is $67.53, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Alabama sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Alabama lands near $95.53, with self-pay cash prices typically around $51.14. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost in Alabama?
The average Medicare payment for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Alabama is $43.42, which is 2% below the national average of $44.34. Providers in AL typically bill $67.53 for this procedure.
What does Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cost with insurance in Alabama?
With commercial insurance in Alabama, Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs an estimated $95.53. Without insurance, the estimated cash price is $51.14. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in Alabama?
45 providers in Alabama billed Medicare for Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative in 2023, performing 262 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative cheaper in Alabama than the national average?
Yes — Test For Detection Of Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Antibody, Qualitative Or Semiquantitative costs 2% below the national average in Alabama. The state average Medicare payment is $43.42 compared to $44.34 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.